194 related articles for article (PubMed ID: 37626865)
1. Unraveling the Role of Toll-like Receptors in the Immunopathogenesis of Selected Primary and Secondary Immunodeficiencies.
Mertowska P; Smolak K; Mertowski S; Grywalska E
Cells; 2023 Aug; 12(16):. PubMed ID: 37626865
[TBL] [Abstract][Full Text] [Related]
2. The Profile of Toll-like Receptor 2 (TLR2), TLR4 and Their Cytosolic Downstream Signaling Pathway in Common Variable Immunodeficiency (CVID) Patients.
Sharifi L; Aghamohammadi A; Rezaei N; Yazdani R; Mahmoudi M; Amiri MM; Masoumi F; Bokaie S; Tavasolian P; Sanaei R; Moshiri M; Tavakolinia N; Alinia T; Azizi G; Mirshafiey A
Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):188-200. PubMed ID: 29757592
[TBL] [Abstract][Full Text] [Related]
3. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
4. Expression of Toll-like Receptors on the Immune Cells in Patients with Common Variable Immune Deficiency after Different Schemes of Influenza Vaccination.
Kostinova AM; Latysheva EA; Akhmatova NK; Vlasenko AE; Skhodova SA; Khromova EA; Linok AV; Poddubikov AA; Latysheva TV; Kostinov MP
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896869
[TBL] [Abstract][Full Text] [Related]
5. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
[TBL] [Abstract][Full Text] [Related]
7. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
Nishiya T; DeFranco AL
J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
[TBL] [Abstract][Full Text] [Related]
8. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
Ballow M; Sánchez-Ramón S; Walter JE
Front Immunol; 2022; 13():928062. PubMed ID: 35924244
[TBL] [Abstract][Full Text] [Related]
9. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity.
Kurt-Jones EA; Sandor F; Ortiz Y; Bowen GN; Counter SL; Wang TC; Finberg RW
J Endotoxin Res; 2004; 10(6):419-24. PubMed ID: 15588425
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of Toll‑like receptors in human breast cancer.
Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G
Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409
[TBL] [Abstract][Full Text] [Related]
11. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
[TBL] [Abstract][Full Text] [Related]
12. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
[TBL] [Abstract][Full Text] [Related]
13. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency and Chronic Lymphocytic Leukemia.
Mertowska P; Mertowski S; Smolak K; Kita A; Kita G; Guz K; Pasiarski M; Grywalska E
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958359
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.
Sheyhidin I; Nabi G; Hasim A; Zhang RP; Ainiwaer J; Ma H; Wang H
World J Gastroenterol; 2011 Aug; 17(32):3745-51. PubMed ID: 21990957
[TBL] [Abstract][Full Text] [Related]
16. Expression of Toll-like receptors by neonatal leukocytes.
Dasari P; Zola H; Nicholson IC
Pediatr Allergy Immunol; 2011 Mar; 22(2):221-8. PubMed ID: 21054549
[TBL] [Abstract][Full Text] [Related]
17. Low expression of Toll-like receptors in peripheral blood mononuclear cells of pediatric patients with acute lymphoblastic leukemia.
Sánchez-Cuaxospa M; Contreras-Ramos A; Pérez-Figueroa E; Medina-Sansón A; Jiménez-Hernández E; Torres-Nava JR; Rojas-Castillo E; Maldonado-Bernal C
Int J Oncol; 2016 Aug; 49(2):675-81. PubMed ID: 27277333
[TBL] [Abstract][Full Text] [Related]
18. Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.
Sánchez-Muñoz F; Fonseca-Camarillo G; Villeda-Ramírez MA; Miranda-Pérez E; Mendivil EJ; Barreto-Zúñiga R; Uribe M; Bojalil R; Domínguez-López A; Yamamoto-Furusho JK
BMC Gastroenterol; 2011 Dec; 11():138. PubMed ID: 22185629
[TBL] [Abstract][Full Text] [Related]
19. The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Stefanko E; Dobrzyńska O; Poręba R; Kuliczkowski K
Leuk Res; 2015 Mar; 39(3):318-22. PubMed ID: 25624047
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1β and interleukin-6 in Common Variable Immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine.
Sharifi L; Aghamohammadi A; Rezaei N; Yazdani R; Rezaei F; Bokaie S; Zavareh FT; Kiaee F; Kamali AN; Azizi G; Mirshafiey A
Eur Cytokine Netw; 2019 Dec; 30(4):123-129. PubMed ID: 32096473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
